PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
26710539-6	2015	Amphotericin B, itraconazole and voriconazole were the most potent antifungal drugs against Paracoccidioides spp (CMI: 0.03-1 microg/mL).	Itraconazole	16-28	histocompatibility minor 13	Homo sapiens	109-112	
17022761-0	2006	Fluconazole and itraconazole susceptibilities of Candida spp.	Itraconazole	16-28	histocompatibility minor 13	Homo sapiens	57-60	
22090300-23	2011	Resistance rates for both fluconazole and itraconazole were higher in biofilm-producers (39.5% and 52.6%, respectively), than those of non-producers (10.6% and 29.8%, respectively), representing a statistical significance (p= 0.002 and p= 0.03, respectively) for Candida spp.	Itraconazole	42-54	histocompatibility minor 13	Homo sapiens	271-274	
17022761-2	2006	This study examined the in vitro susceptibilities to fluconazole and itraconazole of isolates of Candida spp.	Itraconazole	69-81	histocompatibility minor 13	Homo sapiens	105-108	
12654681-0	2003	In vitro synergy of caspofungin and itraconazole against Aspergillus spp.	Itraconazole	36-48	histocompatibility minor 13	Homo sapiens	69-72	
15829804-10	2005	In keratitis due to Fusarium spp, 19 (79%) of 24 patients showed a favorable response to natamycin, which was significantly greater than the 8 (44%) of 18 patients who showed a favorable response to itraconazole (P < 0.02).	Itraconazole	199-211	histocompatibility minor 13	Homo sapiens	29-32	
15829804-13	2005	CONCLUSIONS: Topical natamycin should continue to be considered as the treatment of choice for filamentous fungal keratitis; when natamycin is unavailable, topical itraconazole therapy could be used, particularly if the infections are due to Aspergillus or Curvularia spp.	Itraconazole	164-176	histocompatibility minor 13	Homo sapiens	268-271	
11516940-4	2001	The activities of posaconazole for all the fungal species far surpassed those of fluconazole and were even superior to those of itraconazole for Aspergillus spp.	Itraconazole	128-140	histocompatibility minor 13	Homo sapiens	157-160	
10786463-7	2000	Three weeks into the puerperium, she developed generalised seizures and investigations indicated systemic fungal infection with positive cultures for Aureobasidium spp which responded to appropriate antifungal therapy of flucytosine and itraconazole.	Itraconazole	237-249	histocompatibility minor 13	Homo sapiens	164-167	
10471571-4	1999	While both BMS-207147 and itraconazole displayed a stepwise decrease in activity against isolates for which the fluconazole MICs were elevated, BMS-207147 had two- to fourfold greater activity than itraconazole both against Candida spp.	Itraconazole	26-38	histocompatibility minor 13	Homo sapiens	232-235	
32077323-4	2020	Aim: In the present research, we evaluated the synergistic effects of ketamine with two azole derivatives, itraconazole and fluconazole, on strains of Candida spp.	Itraconazole	107-119	histocompatibility minor 13	Homo sapiens	159-162	
32077323-7	2020	Results: Our achievements showed a synergistic effect between ketamine in addition to the two antifungal agents (fluconazole and itraconazole) against planktonic cells and biofilms of Candida spp.	Itraconazole	129-141	histocompatibility minor 13	Homo sapiens	192-195	
31140972-5	2019	CONCLUSION: Our study illustrated varying degrees of synergism between caspofungin or terbinafine and itraconazole, voriconazole, posaconazole or amphotericin B towards Chaetomium spp., which could be a reference for the clinical treatment of Chaetomium spp.	Itraconazole	102-114	histocompatibility minor 13	Homo sapiens	180-183	
27812353-17	2016	In conclusion, INK128 could enhance the in vitro antifungal activity of voriconazole, itraconazole and posaconazole against Exophiala spp.	Itraconazole	86-98	histocompatibility minor 13	Homo sapiens	134-137